Central Trust Company’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05K | Hold |
19
| – | – | ﹤0.01% | 1365 |
|
|
2025
Q1 | $1.34K | Sell |
19
-42
| -69% | -$2.97K | ﹤0.01% | 1353 |
|
|
2024
Q4 | $4.01K | Hold |
61
| – | – | ﹤0.01% | 1233 |
|
|
2024
Q3 | $4.29K | Sell |
61
-97
| -61% | -$6.82K | ﹤0.01% | 1170 |
|
|
2024
Q2 | $13K | Buy |
158
+50
| +46% | +$4.12K | ﹤0.01% | 1019 |
|
|
2024
Q1 | $9.43K | Buy |
108
+32
| +42% | +$2.8K | ﹤0.01% | 1093 |
|
|
2023
Q4 | $7.33K | Buy |
76
+57
| +300% | +$5.5K | ﹤0.01% | 1111 |
|
|
2023
Q3 | $1.68K | Buy |
+19
| New | +$1.68K | ﹤0.01% | 1279 |
|
|
2022
Q3 | – | Sell |
-14
| Closed | -$1K | – | 1304 |
|
|
2022
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 1268 |
|
|
2022
Q1 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 1288 |
|
|
2020
Q3 | – | Sell |
-83
| Closed | -$10K | – | 1060 |
|
|
2020
Q2 | $10K | Sell |
83
-10
| -11% | -$1.21K | ﹤0.01% | 834 |
|
|
2020
Q1 | $8K | Buy |
+93
| New | +$8K | ﹤0.01% | 892 |
|
|
2017
Q2 | – | Sell |
-8
| Closed | – | – | 1244 |
|
|
2017
Q1 | $0 | Buy |
+8
| New | – | ﹤0.01% | 1148 |
|